Starbucks Corporation Message Board
-
they offer some caveats in the articles they put out
-
the market will probably roll over , for a bit, when they pull the juice
BUT
so much $$$ on the side according to all those who track it I would not sell and just add to any drop 15% or so
take care -
ssys
I see more o/s but that shouldnt be that big of a deal when the pm is sooo much better
LONGS??
THANKS -
but do it quick
fd: long -
yes
-
THANKS
eom
and what do you think about titxf now that they are have hired some team to ( I guess) look for partners?
be bought?
tia -
to get out
then this settle back and then its buying time again
if you like the story here -
now that the stock is noticed even more
this is how it works
jockying for position - Reply to
Motley article saying for 16 months nothing will happen with acad.
by theman111knows •Jun 11, 2013 6:54 PMexactly
the writer was giddy with ACAD but had a contrarian bent
wonder if he is waiting for it to breakout….again -
well….not yet
-
good point all
-
while there is nothing wrong with shorting a stock,,,
many people , some who happen to be shorters of stock,
are just angry and miserable and it hurts them more when others are
happy
those who short and are good people say they are short b/c of a run up etc or they dont like the product
but those who are vitriolic in nature, need the aggravation
and want you to enjoy their misery - Reply to
Amazing how a small amount of shares can effect this stock ,hate to see what happens when
by usagary1 •Jun 11, 2013 9:35 AMcould be shorts covering
most people who know already know
the rest will be MO players and run this up an extra %% when the time comes -
AstraZeneca is to buy U.S. respiratory drug specialist Pearl Therapeutics for up to $1.15 billion, as Britain's second biggest drugmaker steps up a drive to rebuild its product pipeline via deal-making.
The acquisition of the privately held company secures AstraZeneca a position in the emerging market for a new class of lung treatments known as LABA/LAMA drugs that promise improved patient compliance and disease control, without steroids.
Some industry analysts believe that LABA/LAMA inhalers are set to dominate future therapy for chronic obstructive pulmonary disease (COPD), which causes debilitating breathlessness and affects an estimated 210 million people worldwide. -
tips are suppose to protect against inflation
the fact that rates (will) rise should also indicate inflationary environment
BUT THE MANIPULATION OF CPI etc will probably mess this fund up to
socialism is destroying our country -
I am long the stock
but just I would throw that in :) -
i r s
-
any subsidies from their government?
-
as any trader / investor knows
THATS WHY ITS CALLED RISK/ REWARD -
maybe I invest
the article tried to be contrarian but had to come around to kandi
will buy a few
good luck longs